About Hans
Hans Bishop is a Biotech entrepreneur with over 30 years of experience in the industry whose ventures have driven transformative advancements in the field of cancer treatment.
Hans is currently the President, Co-Founder, and Board Co-Chair of Altos Labs. Hans served previously as the CEO of GRAIL, which was acquired by Illumina. In 2013 he co-founded Juno Therapeutics, a company that was dedicated to treating various types of cancer. He served as President and CEO until 2018 when the company was acquired by Celgene.
Hans also serves as the Chairman of Sana Biotechnology’s Board of Directors and held previous board roles at Agilent Technologies and Lyell Immunopharma.